Literature DB >> 11869270

Do we need fourth-generation cephalosporins?

I. M. Gould1.   

Abstract

Entities:  

Year:  1999        PMID： 11869270     DOI： 10.1111/j.1469-0691.1999.tb00717.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN： 1198-743X            Impact factor:   8.067


× No keyword cloud information.
  2 in total

1.  In vitro and in vivo activities of amikacin, cefepime, amikacin plus cefepime, and imipenem against an SHV-5 extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strain.

Authors:  D Szabó; A Máthé; Z Filetóth; P Anderlik; L Rókusz; F Rozgonyi
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

2.  Comparison of the influence on renal function between cefepime and cefpirome.

Authors:  Mingzi Jiang; Jing Yao; L I Zhang; Tianming Gao; Yang Zhang; Xiaoqing Weng; Ganzhu Feng
Journal:  Biomed Rep       Date:  2015-10-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.